The Role of Cardiovascular Rehabilitation in the Elderly Patient

Pablo Díez-Villanueva1, César Jiménez-Méndez2, Héctor García Pardo3

  • 1Cardiology Department, Hospital Universitario La Princesa, Madrid, Spain.

Cardiology
|June 12, 2024
PubMed

Insights

Cardiac rehabilitation (CR) significantly benefits elderly patients with cardiovascular disease, improving outcomes and quality of life. This review highlights CR

Area of Science:

  • Gerontology
  • Cardiology
  • Public Health

Background:

  • Cardiovascular disease (CVD) is a primary cause of death and disability in older adults.
  • Common CVDs include coronary artery disease, heart failure, and peripheral artery disease.
  • Elderly patients often present with comorbidities and frailty, complicating CVD management.

Purpose of the Study:

  • To review the benefits of cardiac rehabilitation (CR) in the elderly population with established CVD.
  • To propose a framework for personalized CR strategies in older adults.
  • To emphasize the importance of addressing frailty in elderly CVD patients.

Main Methods:

  • Systematic review of existing literature on CR for elderly patients.
  • Analysis of CR's impact on cardiovascular outcomes, functional independence, and quality of life.
  • Examination of CR's role in managing cardiovascular risk factors and geriatric syndromes.

Main Results:

  • CR is associated with significant cardiovascular benefits in older adults.
  • CR improves functional independence and quality of life.
  • Elderly patients are under-referred to CR compared to younger individuals.

Conclusions:

  • CR offers substantial benefits for elderly patients with cardiovascular disease.
  • Personalized CR programs, integrating geriatric care, are crucial.
  • Addressing frailty and comorbidities enhances CR effectiveness in older populations.
Abstract

Related Concept Videos

Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
784
Exercise and Cardiac Output01:17

Exercise and Cardiac Output

Regular physical activity is essential for maintaining cardiovascular health, with aerobic exercises being particularly effective. According to the American Heart Association, 150 minutes of moderate to intense aerobic exercise per week is recommended for a healthy heart. Aerobic activities may include brisk walking, running, bicycling, cross-country skiing, and swimming, ideally performed three to five times per week.
Sustained exercise increases the muscles' oxygen demand, which can be...
985
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
421
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
316
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
336
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K